险资方向，本期较上一期持股增加的险资共计2个，包括前海人寿保险股份有限公司-分红保险产品华泰 组合、前海人寿保险股份有限公司-分红保险产品，持股增加占比达0.2%。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 2025年8月9日，三鑫医疗(300453.SZ)发布2025年半年度报告。截至2025年8月08日，共有7个机构投资 者披露持有三鑫医疗A股股份，合计持股量达3422.78万股，占三鑫医疗总股本的6.55%。其中，机构投 资者包括前海人寿保险股份有限公司-分红保险产品华泰组合、前海人寿保险股份有限公司-分红保险产 品华泰组合、前海人寿保险股份有限公司-分红保险产品、前海人寿保险股份有限公司-分红保险产品、 大成创业板两年定开混合A、诺安主题精选混合、汇安资产轮动混合A，机构投资者合计持股比例达 6.55%。相较于上一季度，机构持股比例合计上涨了1.00个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即汇安资产轮动混合A，持股增加占比小 幅上涨。本期较上一季度新披露的公募基金共计2个，包括大成创业板两年定开混合A、诺安主题精选 混合。本期较上一季未再披露的公 ...

Core Viewpoint - Shenzhen Kesi Technology Co., Ltd. has announced a share repurchase plan approved by its board of directors, indicating a strategic move to enhance shareholder value and potentially stabilize the stock price [1]. Group 1: Share Repurchase Announcement - The company held its 21st meeting of the 3rd board of directors on May 5, 2025, where it approved the share repurchase plan [1]. - The announcement regarding the share repurchase plan was disclosed on May 6, 2025, on the Shanghai Stock Exchange [1]. Group 2: Shareholder Information - The company provided details on the top ten shareholders and their respective shareholding proportions as of the equity registration date of May 12, 2025 [1]. - The shareholding data includes both ordinary accounts and margin trading accounts, reflecting the total holdings of the shareholders [2].